Pacira enrolls first patient in PCRX-201 Phase 2 study Part B

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AAPL
6. HOOD
7. QCOM
8. ACN
9. AZN
10. ROIV

Go back to Pacira enrolls first patient in PCRX-201 Phase 2 study Part B
PACIRA (NASDAQ: PCRX) Delayed: 25.87 -0.48 (1.82%)
Previous Close $26.35    52 Week High $80.25 
Open $25.98    52 Week Low $30.25 
Day High $26.41    P/E N/A 
Day Low $25.68    EPS $-2.08 
Volume 386,425